PRL-3 inhibition increased apoptosis in T-ALL cells after 24 h, although this trend was not significant across multiple experiments (Supplemental Fig. 7A), with no effect on cell cycle, measured by EdU uptake (Supplemental Fig. 7B). Here, PTP4A3 is linked to acute lymphoblastic leukemia.